1. 103 AZACITIDINE TREATMENT OF HIGH RISK MDS AND AML, ANALYSIS OF LONG RESPONDING PATIENTS AND PROGNOSTIC FACTORS OF OVERALL SURVIVAL, CZECH MDS GROUP EXPERIENCE. Issue 1 (April 2015) Authors: Jonasova, A.; Cermak, J.; Cervinek, L.; Belohlavkova, P.; Cerna, O.; Kacmarova, K.; Janousova, E. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 106 PATIENTS WITH TWO UNRELATED CLONES DEL(5Q) AND TRISOMY 8 – A SUBTYPE OF 5Q- SYNDOME? UNCERTAIN PROGNOSIS OF PATIENTS WITH DECREASED DEL(5Q) CLONE DUE TO LENALIDOMIDE. Issue 1 (April 2015) Authors: Neuwirtova, R.; Zemanova, Z.; Brezinova, J.; Michalova, K.; Dvorak, P.; Oltova, A.; Belickova, M.; Fuchs, O.; Cermak, J.; Jonasova, A. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 117 A PHASE 3 STUDY OF LENALIDOMIDE VERSUS PLACEBO IN RBC TRANSFUSION-DEPENDENT (TD) PATIENTS WITH LOWER-RISK MDS WITHOUT DEL(5Q) UNRESPONSIVE OR REFRACTORY TO ERYTHROPOIESIS-STIMULATING AGENTS (ESAS). Issue 1 (April 2015) Authors: Santini, V.; Almeida, A.; Giagounidis, A.; Gröpper, S.; Jonasova, A.; Vey, N.; Mufti, G.J.; Buckstein, R.; Mittelman, M.; Platzbecker, U.; Shpilberg, O.; Ram, R.; del Canizo, C.; Gattermann, N.; Ozawa, K.; Risueno, A.; MacBeth, K.J.; Zhong, J.; Séguy, F.; Hoenekopp, A. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 167 ALTERED EXPRESSION OF THE REPAIR GENES IN CD34+ CELLS MAY BE RESPONSIBLE FOR FORMATION AND ACCUMULATION OF MUTATIONS IN MDS PATIENTS. Issue 1 (April 2015) Authors: Valka, J.; Belickova, M.; Vesela, J.; Stara, E.; Planetova, B.; Jonasova, A.; Cermak, J. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 170 MECHANISM OF FORMATION OF COMPLEX CHROMOSOMAL ABERRATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS): CLONAL EVOLUTION OR CHROMOTHRIPSIS?. Issue 1 (April 2015) Authors: Zemanova, Z.; Michalova, K.; Brezinova, J.; Lhotska, H.; Svobodova, K.; Sarova, I.; Lizcova, L.; Izakova, S.; Ransdorfova, S.; Krejcik, Z.; Belickova, M.; Siskova, M.; Jonasova, A.; Neuwirtova, R.; Cermak, J. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 232 THE SIGNIFICANCE OF TRANSCRIPTION FACTORS FLI1 AND P53 FOR THE EFFECTIVE MEGAKARYOPOIESIS STUDIED IMMUNOHISTOCHEMICALLY IN 5Q- SYNDROME AND THE EFFECT OF LENALIDOMIDE TREATMENT. Issue 1 (April 2015) Authors: Campr, V.; Stritesky, J.; Neuwirtova, R.; Fuchs, O.; Jonasova, A. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 277 ASXL1 GENE MUTATIONS ACCUMULATE IN AZACITIDINE-TREATED MDS PATIENTS AND ASSOCIATE WITH ADVERSE PROGNOSIS. Issue 1 (April 2015) Authors: Stopka, T.; Vargova, K.; Kulvait, V.; Vargova, J.; Dusilkova, N.; Jonasova, A. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 42 THE EFFICACY OF LENALIDOMIDE IN LOWER RISK MYELODYSPLASTIC SYNDROME WITH ISOLATED 5Q DELETION IS DEPENDENT ON HIGH LEVEL OF FULL-LENGTH CEREBLON MESSENGER RNA. (April 2015) Authors: Fuchs, O.; Polak, J.; Bokorova, R.; Vostry, M.; Kostecka, A.; Hajkova, H.; Neuwirtova, R.; Siskova, M.; Cermak, J.; Sponerova, D.; Lauermannova, M.; Soukupova, J.; Cervinek, L.; Brezinova, J.; Michalova, K.; Jonasova, A. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 49 THE PROGNOSTIC SIGNIFICANCE OF TP53 MUTATIONS IN MDS PATIENTS WITH DEL(5Q). (April 2015) Authors: Belickova, M.; Vesela, J.; Jonasova, A.; Planetova, B.; Valka, J.; Mikulenkova, D.; Zemanova, Z.; Brezinova, J.; Michalova, K.; Cermak, J. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Allogeneic venous grafts used for portal vein reconstruction after pancreaticoduodenectomy - large animal experiment and biomechanical study. (2020) Authors: Palek, R.; Jonasova, A.; Rosendorf, J.; Mik, P.; Bajcurova, K.; Hosek, P.; Moulisova, V.; Haidingerova, L.; Brzon, O.; Eberlova, L.; Bednar, L.; Kriz, T.; Dolansky, M.; Treska, V.; Tonar, Z.; Vimmr, J.; Liska, V. Journal: HPB Issue: Volume 22(2020)Supplement 2 Page Start: S245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗